This inventor holds 41 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 12 EPO patents, primarily in Cancer Therapeutics. Top assignees: Bristol-Myers Squibb Compnay, Rutgers, The State University of New Jersey, Lexicon Pharmaceuticals, Inc.. Active years: 1998-2025.
Location History:
- Kenosha, WI (US) (1998 - 2004)
- Emerson, NJ (US) (2005 - 2010)
- Princeton, NJ (US) (2001 - 2020)
- New Brunswick, NJ (US) (2019 - 2020)
Company Filing History:
11 out of 3,735 
10 out of 1,492 
9 out of 89 
Years Active: 1998-2025
Areas of Expertise:
Title: David John Augeri: Innovator in Pharmaceutical Compounds
Introduction
David John Augeri is a distinguished inventor based in Princeton, NJ, who has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 40 patents, Augeri's work primarily focuses on innovative compounds and therapeutic methods aimed at treating cancer and other serious diseases.
Latest Patents
Among his latest inventions are groundbreaking pharmaceutical compounds designed to treat cancer, specifically targeting glioblastoma. One notable patent introduces compounds of formula (16) and (17) that possess exceptional potency, permeability, and oral bioavailability. These compounds, salts, and complexes are developed to inhibit BMI1 expression and treat Huntington's disease. Another patent presents a compound of formula I that serves as an effective anti-cancer agent, showcasing the therapeutic potential of his inventions in modern medicine.
Career Highlights
Throughout his successful career, David John Augeri has collaborated with leading pharmaceutical companies, including Bristol-Myers Squibb Company and Lexicon Pharmaceuticals, Inc. His innovative spirit and dedication to advancements in healthcare have made him a valuable asset in the industry.
Collaborations
Augeri has worked alongside esteemed colleagues, including Lawrence G. Hamann and Wang Shen. These collaborations have fostered a productive environment conducive to innovation and the development of new therapeutic solutions.
Conclusion
David John Augeri’s contributions to the field of pharmaceuticals and his extensive patent portfolio underline his role as a pivotal inventor in the fight against cancer and other critical health challenges. His work not only reflects his expertise but also his commitment to enhancing the quality of medical treatments available today.